BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS




Industry
Healthcare

Segment
Pharmaceuticals

Collaborations

Gilead (Durham, NC) 





 Company News
Jennifer Saputo Joins Astellas Pharma Inc. (ALPMY) Corporate Affairs 4/15/2015 10:39:00 AM
Ventana Medical Systems, Inc. (VMSI) And Astellas Pharma Inc. (ALPMY) Join Forces To Leverage Novel Companion Diagnostic Tests For Targeted Cancer Treatments 4/14/2015 9:16:33 AM
Astellas Pharma Inc. (ALPMY) Appoints Shontelle Dodson To Lead Medical Excellence Function 4/6/2015 10:17:24 AM
MD Anderson Cancer Center, Astellas Pharma Inc. (ALPMY) Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 4/3/2015 7:13:13 AM
Astellas Pharma Inc. (ALPMY) Release: Enzalutamide Demonstrates Statistically Significant Improvement In Progression Free Survival Compared With Bicalutamide In Strive Trial 4/2/2015 6:56:36 AM
Vical Incorporated (VICL) Expands Infectious Disease Portfolio With Novel Antifungal From Astellas Pharma Inc. (ALPMY) 3/26/2015 11:09:54 AM
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Announce New Enzalutamide Data Presented During Plenary Presentations At The 2015 European Association Of Urology Congress 3/24/2015 9:42:26 AM
Astellas Pharma Inc. (ALPMY) Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 3/9/2015 6:55:23 AM
Astellas Pharma Inc. (ALPMY) Broadens Regional Leadership And Creates New Corporate Affairs And Corporate Development Functions 2/20/2015 8:39:37 AM
Astellas Pharma Inc. (ALPMY) Launches The Newest Element In Its Global Corporate Brand Campaign On CNN's Global Broadcast Network 2/16/2015 11:39:06 AM
12345678910...